Group Behaviour in Chronic Schizophrenics Treated with "Meratran"

Houston, Fred

doi:10.1136/bmj.1.4973.949

Cited by 10 publications

(1 citation statement)

References 2 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There is no doubt that they are unscientific in that there are always uncontrolled (and in part unknown) variables. The benefit of the trial per se on staff and patients has been stressed (Houston, 1956;Forrest, 1957). The patients involved in the trial reported here are very â€oe¿ sophisticatedâ€•, that is, the majority have been in previous trials of reserpine and azocyclonal.…”

Section: Introduction the Last Few Years Have Producedmentioning

confidence: 96%

Clinical Trial of Promazine Hydrochloride and Acetylpromazine in Chronic Schizophrenic Patients

Urquhart

Forrest

1959

J. ment. sci

View full text Add to dashboard Cite

The last few years have produced an extensive literature on the chemotherapy of schizophrenia (Foote, 1955; Shepherd and Watt, 1956; Wing, 1956; Kinross-Wright, 1957). Enthusiastic reports continue to appear in the American journals (Feldman, 1957; Winkelman, 1957) whereas a more cautious note is usually struck in psychiatric papers published in this country. The value of reserpine is now generally accepted (Moore and Mankin, 1957; Elkes, 1957) but it is not without dangerous side-effects (Wardell, 1957). Chlorpromazine is now used extensively and is probably a safer drug; the danger of jaundice has not proved to be a real contra-indication to the use of the drug. However, reports of deaths during treatment with chlorpromazine have been published (Stënback, 1956).

show abstract

Section: Introduction the Last Few Years Have Producedmentioning

confidence: 96%